Yiming (Beijing) Cell Biotechnology Co., Ltd. announced that it has raised $30 million in funding led by Goldstone Investment Group Limited and CLSA Capital Partners on September 27, 2022. THe transaction also includes participation from BGI Co-Win, Wenzhou Capital, Finnova Capital, IDG Capital Partners Co., Ltd. and Xingtou Capital, and existing investor Beijing FOF Capital Co.,Ltd., Huagai Capital Co., Ltd.